Analysts Set Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Price Target at $5.53
Analysts Set Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Price Target at $5.53
Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Rating) have earned an average recommendation of "Moderate Buy" from the ten research firms that are currently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $5.33.
據Marketbeats報道，目前追蹤Aveanna Healthcare Holdings Inc.的十家研究公司對Aveanna Healthcare Holdings Inc.(納斯達克代碼：AVAH-GET)的股票平均推薦為“適度買入”。一名投資分析師對該股的評級為賣出，兩名分析師給予持有評級，四名分析師給予買入評級，一名分析師對該公司發出了強烈的買入評級。在去年更新了該股覆蓋範圍的經紀商中，12個月目標價的平均水平為5.33美元。
AVAH has been the subject of a number of research reports. Raymond James lowered their price target on Aveanna Healthcare from $8.00 to $6.00 and set a "strong-buy" rating for the company in a research report on Monday, August 15th. Barclays lowered their price target on Aveanna Healthcare from $7.00 to $5.00 and set an "overweight" rating for the company in a research report on Friday, August 19th. Truist Financial cut Aveanna Healthcare from a "buy" rating to a "hold" rating and set a $2.50 price objective on the stock. in a research note on Tuesday, July 5th. Stephens reduced their price objective on Aveanna Healthcare to $2.75 in a research note on Friday, July 22nd. Finally, Credit Suisse Group reduced their price objective on Aveanna Healthcare to $5.50 in a research note on Friday, July 22nd.
Avah已經成為許多研究報告的主題。雷蒙德·詹姆斯在8月15日(星期一)的一份研究報告中將Aveanna Healthcare的目標價從8.00美元下調至6.00美元，併為該公司設定了“強力買入”評級。巴克萊在8月19日週五的一份研究報告中將Aveanna Healthcare的目標價從7.00美元下調至5.00美元，並對該公司設定了“增持”評級。Truist Financial將Aveanna Healthcare的評級從“買入”下調至“持有”，併為該股設定了2.50美元的目標價。在7月5日星期二的一份研究報告中。斯蒂芬斯在7月22日星期五的一份研究報告中將Aveanna Healthcare的目標價下調至2.75美元。最後，瑞士信貸集團在7月22日星期五的一份研究報告中將Aveanna Healthcare的目標價下調至5.50美元。
Institutional Inflows and Outflows
機構資金流入和流出
Several institutional investors have recently modified their holdings of AVAH. Qube Research & Technologies Ltd raised its stake in Aveanna Healthcare by 38.7% during the fourth quarter. Qube Research & Technologies Ltd now owns 42,169 shares of the company's stock valued at $312,000 after buying an additional 11,762 shares in the last quarter. Arizona State Retirement System acquired a new stake in Aveanna Healthcare during the fourth quarter valued at approximately $92,000. Envestnet Asset Management Inc. raised its stake in Aveanna Healthcare by 33.8% during the fourth quarter. Envestnet Asset Management Inc. now owns 22,794 shares of the company's stock valued at $169,000 after buying an additional 5,758 shares in the last quarter. Northern Trust Corp raised its stake in Aveanna Healthcare by 3.4% during the fourth quarter. Northern Trust Corp now owns 379,266 shares of the company's stock valued at $2,807,000 after buying an additional 12,440 shares in the last quarter. Finally, Swiss National Bank acquired a new stake in Aveanna Healthcare during the fourth quarter valued at approximately $750,000. Institutional investors and hedge funds own 95.00% of the company's stock.
幾家機構投資者最近調整了對Avah的持股。Qube Research&Technologies Ltd在第四季度將其在Aveanna Healthcare的持股增加了38.7%。Qube Research&Technologies Ltd現在擁有42,169股該公司股票，價值312,000美元，上個季度又購買了11,762股。亞利桑那州退休系統在第四季度收購了Aveanna Healthcare的新股份，價值約92,000美元。Envestnet Asset Management Inc.在第四季度將其在Aveanna Healthcare的持股增加了33.8%。Envestnet Asset Management Inc.現在持有22,794股該公司股票，價值16.9萬美元，該公司在上個季度又購買了5,758股。北方信託公司在第四季度將其在Aveanna Healthcare的持股增加了3.4%。Northern Trust Corp目前持有379,266股該公司股票，價值2,807,000美元，此前該公司在上個季度又購買了12,440股。最後，瑞士國家銀行在第四季度收購了Aveanna Healthcare的新股份，價值約75萬美元。機構投資者和對衝基金持有該公司95.00%的股票。
Aveanna Healthcare Price Performance
Aveanna醫療保健價格表現
Aveanna Healthcare (NASDAQ:AVAH – Get Rating) last announced its quarterly earnings data on Wednesday, August 10th. The company reported $0.03 EPS for the quarter, missing analysts' consensus estimates of $0.06 by ($0.03). Aveanna Healthcare had a negative net margin of 33.32% and a positive return on equity of 9.57%. During the same period in the previous year, the company posted $0.08 earnings per share. Equities research analysts forecast that Aveanna Healthcare will post 0.16 EPS for the current year.
Aveanna Healthcare(納斯達克：AVA-GET評級)最近一次公佈季度收益數據是在8月10日星期三。該公司公佈本季度每股收益為0.03美元，低於分析師普遍預期的0.06美元(0.03美元)。Aveanna Healthcare的淨利潤率為負33.32%，股本回報率為正9.57%。去年同期，該公司公佈的每股收益為0.08美元。股票研究分析師預測，Aveanna Healthcare本年度每股收益將達到0.16股。
About Aveanna Healthcare
關於Aveanna Healthcare
(Get Rating)
(獲取評級)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides private duty nursing (PDN), adult home health and hospice, home-based pediatric therapy, and enteral nutrition services in the United States. Its patient- centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals.
Aveanna Healthcare Holdings Inc是一家多元化的家庭護理平臺公司，在美國提供私人值班護理(PDN)、成人家庭健康和臨終關懷、家庭兒科治療和腸內營養服務。其以患者為中心的護理交付平臺允許患者留在家裏，並最大限度地減少對醫院等高成本護理機構的過度利用。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on Aveanna Healthcare (AVAH)
- Are Ocugen or Amarin Good Penny Stocks to Buy?
- Are These 2 Fintechs A Buy After Q2 Earnings?
- Is Fisker Ready to Re-Emerge as the Tesla Killer?
- Chipotle is Cooking Up Another Run at $2,000
- Dick's Sporting Goods Lifted By Institutional Shift
- 免費獲取StockNews.com關於Aveanna Healthcare(Avah)的研究報告
- Ocugen或Amarin是值得購買的便士股票嗎？
- 這兩家金融科技公司是在第二季度盈利後買入的嗎？
- 菲斯克準備好重新成為特斯拉殺手了嗎？
- Chipotle正在醖釀另一輪2000美元的漲勢
- 迪克的體育用品被制度變遷提振
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
接受Aveanna Healthcare Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Aveanna Healthcare和相關公司的最新新聞和分析師評級的每日簡要摘要。